|
Stem cell types | RNA methylation | Writer | Eraser | Reader | Related function | Reference |
|
Embryonic stem cells (ESCs) | m6A | METTL14 | | | ESC stemness and differentiation | [35] |
m6A m6A m6A | METTL3 METTL3, WTAP METTL5 | | | Naive pluripotency ESC differentiation ESC pluripotency and differentiation | [36] [37] [12, 38] |
m6A | WTAP-Virilizer-Hakai | | | ESC self-renewal and differentiation | [39] |
m6A | METTL3-METTL14-WTAP | | | Early cell fate determination and pluripotency | [70] |
m6A | | FTO | | ESC pluripotency | [40] |
m6A | | | YTHDF3 | ESC pluripotency | [41] |
m6A | METTL3 | | YTHDC1 | Chromatin accessibility and transcription | [42] |
m6A | | | YTHDF1/2/3 | ESC differentiation | [43] |
m5C | NSUN3 | | | ESC proliferation and differentiation | [94] |
U-tail | | | DIS3L2 | ESC differentiation | [101] |
|
Hematopoietic stem cells (HSCs) | m6A | METTL3 | | | Cell differentiation and cell proliferation Endothelial-to-hematopoietic transition The maintenance of HSC identity and symmetric commitment | [47, 49–51] |
m6A | | | YTHDF2 | Endothelial-to-hematopoietic transition HSC self-renewal | [51, 52] |
m6A | METTL14 | | | Terminal myeloid differentiation of normal HSPCs | [53] |
|
Neural stem cells (NSCs) | m6A | METTL3 | | | Proliferation and differentiation of adult NSCs Neuronal development and neurogenesis | [55] |
m6A | METTL14 | | | NSC proliferation and differentiation | [57] |
m6A | | FTO | | Proliferation and neuronal differentiation of adult NSCs | [58, 59] |
m6A | | | YTHDF2 | Self-renewal, proliferation, and differentiation of NSCs | [60] |
m5C | NSUN2 | | | Migration and differentiation of neuroepithelial stem and progenitor cells | [95] |
|
Bone marrow mesenchymal stem cells (BMSCs) | m6A | METTL3 | | | BMSC differentiation | [62–66] |
m6A | | FTO | | MSC differentiation | [67] |
m6A | | | YTHDF2 | Adipogenesis | [62] |
|
Induced pluripotent stem cells (iPSCs) | m6A | METTL3 | | YTHDF1/YTHDF2 | Self-renewal and pluripotency of iPSCs | [69, 72] |
m6A | METTL3-METTL14-WTAP | | | Early cell fate determination and pluripotency | [70] |
| | | YTHDF2 YTHDF3 | iPSC reprogramming | [71] |
U-tail | TUT7 | | | The neural differentiation of primed PSCs | [98] |
|
Cancer stem cells (CSCs) | m6A | METTL3 | | | Myeloid leukemia cell differentiation and apoptosis Maintenance of the leukemic state Colorectal CSC stemness phenotype and metastasis of CRC GSC maintenance and dedifferentiation of glioma cells GSC growth, self-renewal, and tumor progression | [47, 74, 78, 80–83] |
m6A | METTL14 | | | Development and maintenance of AML self-renewal of leukemia stem and initiation cells GSC growth, self-renewal, and tumor progression | [53, 83] |
m6A | | | YTHDF2 | The overall integrity of LSC function GSC growth | [77, 88] |
m6A | | | YTHDF1 | CRC CSC marker expression GBM tumorigenesis | [79, 87] |
m6A | | ALKBH5 | | LSC self-renewal and function Self-renewal, proliferation, and tumorigenesis of GSCs Radioresistance and invasiveness of GSCs BCSC phenotypes and breast cancer metastasis | [75, 76, 84, 85, 91] |
m6A | | FTO | | GSC growth, self-renewal, and tumor progression | [83, 86] |
m6A | | | IGF2BP2 | CRC stemness and metastasis | [78] |
| | | IGF2BP1 | Self-renewal and stemness maintenance of BCSCs | [92] |
U-tail | | | DIS3L2 | CSC properties | [102] |
|